Business Model Innovation in Pharmaceutical industry: Service Orientation Perspective
Wei-Jen Chen and
Advances in Management and Applied Economics, 2019, vol. 9, issue 6, 7
This study zooms in on the pharmaceutical industry and incorporates the perspectives of the service economy, in order to explore the possible frameworks for business model innovations. Business model innovation is gaining attention now, but still few researches compared with literatures of service innovation. An in-depth study of BMI is important for both theoretical exploration and business practice. The main objectives of this research are: (1) Construct an analytical typology of BMI in pharmaceutical industry; (2) Establish an BMI analyticalÂ model for pharmaceutical industry in Taiwan; (3) Based on the above-mentioned indicator establishing process and results, make suggestions for future researchers and recommend useful strategies for enterprises. Â JEL classification numbers: C83, M15, O31
Keywords: Business Model Innovation (BMI); Pharmaceutical Industry; Service Innovation; Fuzzy Hierarchy Analysis Method (search for similar items in EconPapers)
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:spt:admaec:v:9:y:2019:i:6:f:9_6_7
Access Statistics for this article
More articles in Advances in Management and Applied Economics from SCIENPRESS Ltd
Bibliographic data for series maintained by Eleftherios Spyromitros-Xioufis ().